These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 14748811)

  • 21. Drug-Associated Acute Kidney Injury Identified in the United States Food and Drug Administration Adverse Event Reporting System Database.
    Welch HK; Kellum JA; Kane-Gill SL
    Pharmacotherapy; 2018 Aug; 38(8):785-793. PubMed ID: 29883524
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Facilitating adverse drug event detection in pharmacovigilance databases using molecular structure similarity: application to rhabdomyolysis.
    Vilar S; Harpaz R; Chase HS; Costanzi S; Rabadan R; Friedman C
    J Am Med Inform Assoc; 2011 Dec; 18 Suppl 1(Suppl 1):i73-80. PubMed ID: 21946238
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mining multi-item drug adverse effect associations in spontaneous reporting systems.
    Harpaz R; Chase HS; Friedman C
    BMC Bioinformatics; 2010 Oct; 11 Suppl 9(Suppl 9):S7. PubMed ID: 21044365
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The application of knowledge discovery in databases to post-marketing drug safety: example of the WHO database.
    Bate A; Lindquist M; Edwards IR
    Fundam Clin Pharmacol; 2008 Apr; 22(2):127-40. PubMed ID: 18248442
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An Alternative to Disproportionality: A Frequency-Based Method for Pharmacovigilance Data Mining.
    Jokinen JD; Lievano F; Scarazzini L; Truffa M
    Ther Innov Regul Sci; 2018 May; 52(3):294-299. PubMed ID: 29714535
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The value of time-to-onset in statistical signal detection of adverse drug reactions: a comparison with disproportionality analysis in spontaneous reports from the Netherlands.
    Scholl JH; van Puijenbroek EP
    Pharmacoepidemiol Drug Saf; 2016 Dec; 25(12):1361-1367. PubMed ID: 27686554
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adverse drug event reporting systems: a systematic review.
    Bailey C; Peddie D; Wickham ME; Badke K; Small SS; Doyle-Waters MM; Balka E; Hohl CM
    Br J Clin Pharmacol; 2016 Jul; 82(1):17-29. PubMed ID: 27016266
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessing the extent and impact of the masking effect of disproportionality analyses on two spontaneous reporting systems databases.
    Maignen F; Hauben M; Hung E; Van Holle L; Dogne JM
    Pharmacoepidemiol Drug Saf; 2014 Feb; 23(2):195-207. PubMed ID: 24243665
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A pharmacovigilance study of pharmacokinetic drug interactions using a translational informatics discovery approach.
    Wang L; Shendre A; Chiang CW; Cao W; Ning X; Zhang P; Zhang P; Li L
    Br J Clin Pharmacol; 2022 Feb; 88(4):1471-1481. PubMed ID: 33543792
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Useful Interplay Between Spontaneous ADR Reports and Electronic Healthcare Records in Signal Detection.
    Pacurariu AC; Straus SM; Trifirò G; Schuemie MJ; Gini R; Herings R; Mazzaglia G; Picelli G; Scotti L; Pedersen L; Arlett P; van der Lei J; Sturkenboom MC; Coloma PM
    Drug Saf; 2015 Dec; 38(12):1201-10. PubMed ID: 26370104
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A data-driven method to detect adverse drug events from prescription data.
    Zhan C; Roughead E; Liu L; Pratt N; Li J
    J Biomed Inform; 2018 Sep; 85():10-20. PubMed ID: 30016721
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of statistical signal detection methods within and across spontaneous reporting databases.
    Candore G; Juhlin K; Manlik K; Thakrar B; Quarcoo N; Seabroke S; Wisniewski A; Slattery J
    Drug Saf; 2015 Jun; 38(6):577-87. PubMed ID: 25899605
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Data-mining characteristics of adverse drug reactions and pharmacovi-gilance of Chinese patent drugs including Aconitum herbs].
    Zhang XM; Li F; Zhang B; Chen XF; Piao JZ
    Zhongguo Zhong Yao Za Zhi; 2018 Jan; 43(2):216-221. PubMed ID: 29552835
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A meta-epidemiological study found lack of transparency and poor reporting of disproportionality analyses for signal detection in pharmacovigilance databases.
    Khouri C; Revol B; Lepelley M; Mouffak A; Bernardeau C; Salvo F; Pariente A; Roustit M; Cracowski JL
    J Clin Epidemiol; 2021 Nov; 139():191-198. PubMed ID: 34329725
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Role and Applicability of Spontaneous Reporting Databases in Medical Big Data].
    Sakai T
    Yakugaku Zasshi; 2021; 141(2):165-168. PubMed ID: 33518634
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Triptans and serious adverse vascular events: data mining of the FDA Adverse Event Reporting System database.
    Roberto G; Piccinni C; D'Alessandro R; Poluzzi E
    Cephalalgia; 2014 Jan; 34(1):5-13. PubMed ID: 23921799
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Retrofitting Vector Representations of Adverse Event Reporting Data to Structured Knowledge to Improve Pharmacovigilance Signal Detection.
    Ding X; Cohen T
    AMIA Annu Symp Proc; 2020; 2020():383-392. PubMed ID: 33936411
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of two drug safety signals in a pharmacovigilance data mining framework.
    Tubert-Bitter P; Bégaud B; Ahmed I
    Stat Methods Med Res; 2016 Apr; 25(2):615-29. PubMed ID: 23070598
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Harnessing scientific literature reports for pharmacovigilance. Prototype software analytical tool development and usability testing.
    Sorbello A; Ripple A; Tonning J; Munoz M; Hasan R; Ly T; Francis H; Bodenreider O
    Appl Clin Inform; 2017 Mar; 8(1):291-305. PubMed ID: 28326432
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessment of the Utility of Social Media for Broad-Ranging Statistical Signal Detection in Pharmacovigilance: Results from the WEB-RADR Project.
    Caster O; Dietrich J; Kürzinger ML; Lerch M; Maskell S; Norén GN; Tcherny-Lessenot S; Vroman B; Wisniewski A; van Stekelenborg J
    Drug Saf; 2018 Dec; 41(12):1355-1369. PubMed ID: 30043385
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.